Cantor Fitzgerald Defends Nano-X Imaging (NNOX) Following Short Report

September 15, 2020 1:21 PM EDT
Get Alerts NNOX Hot Sheet
Price: $24.27 +1.85%

Rating Summary:
    3 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 13 | New: 52
Trade Now! 
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Cantor Fitzgerald analyst Steven Halper reiterated an Overweight rating and $70.00 price target on Nano-X Imaging (NASDAQ: NNOX), defending the stock following weakness due to a new short-seller report.

The analyst commented, "We reiterate our Overweight rating on the shares and our price target remains at $70. This morning, the shares traded lower, due, presumably, to a report that questions the legitimacy of the company's growth potential. We will address four areas, including data, R&D spend, FDA and customer orders. On published data, we note that the prototype device has been in place at Hadassah hospital in Jerusalem, a large and well-known hospital in Israel. Data used for the FDA was gathered at this site. With respect to FDA, it is certainly customary for device companies to use a 510(k) approval process, which compares the device to predicate technology. The regulatory threshold is much lower when you are proving comparability. On R&D spend, NNOX acquired the technology from Sony (SNE - NC), which, according to its CEO, spent $1 billion on the technology before the acquisition. Finally, with respect to customer orders, we are very comfortable with the clients that were disclosed in the company's filings (representing about 4,500 units). We note the company recently signed a new contract for another 630 units and has good visibility on another 5,500 units. We continue to expect the company to install 15,000 units by 2024 and for peak revenue to reach $900 million by 2026."

For an analyst ratings summary and ratings history on Nano-X Imaging click here. For more ratings news on Nano-X Imaging click here.

Shares of Nano-X Imaging closed at $49.21 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Short Sales, Trader Talk

Related Entities

Cantor Fitzgerald, Definitive Agreement, FDA